New insulin candidate put to the test in healthy volunteers
NCT ID NCT07591519
First seen May 24, 2026 · Last updated Jun 12, 2026 · Updated 4 times
Summary
This early-stage study tests whether a new insulin formula (IBI3035) works similarly to an approved insulin (Awiqli) in healthy men. Researchers will measure how the drug moves through the body and how it affects blood sugar after a single injection. The goal is to gather safety and effectiveness data, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PERSON are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Bishan Hospital of Chongqing
Chongqing, Chongqing Municipality, 402760, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.